The multifunctional protein HMGB1: 50 years of discovery

[1]  F. Greten,et al.  Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade , 2023, Gut.

[2]  M. Ciriolo,et al.  The telomeric protein TERF2/TRF2 impairs HMGB1-driven autophagy , 2022, Autophagy.

[3]  Weiming Zhu,et al.  Hypoxic ASCs-derived Exosomes Attenuate Colitis by Regulating Macrophage Polarization via miR-216a-5p/HMGB1 Axis. , 2022, Inflammatory bowel diseases.

[4]  Yue Ding,et al.  The HMGB1 (C106A) mutation inhibits IL-10-producing CD19hiFcγRIIbhi B cell expansion by suppressing STAT3 activation in mice , 2022, Frontiers in Immunology.

[5]  Ja-Kyeong Lee,et al.  Cytosolic HMGB1 Mediates LPS-Induced Autophagy in Microglia by Interacting with NOD2 and Suppresses Its Proinflammatory Function , 2022, Cells.

[6]  T. Schall,et al.  Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias , 2022, Science advances.

[7]  J. Wenke,et al.  Neutralization of HMGB1 improves fracture healing and γδ T lymphocyte counts at the fracture site in a polytrauma rat model , 2022, Journal of Experimental Orthopaedics.

[8]  X. Bian,et al.  Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization , 2022, Journal of Experimental & Clinical Cancer Research.

[9]  D. Tang,et al.  The mechanism of HMGB1 secretion and release , 2022, Experimental & Molecular Medicine.

[10]  A. Karsan,et al.  TIRAP drives myelosuppression through an Ifnγ–Hmgb1 axis that disrupts the endothelial niche in mice , 2022, The Journal of experimental medicine.

[11]  Xia Li,et al.  HMGB1-Mediated Neutrophil Extracellular Trap Formation Exacerbates Intestinal Ischemia/Reperfusion-Induced Acute Lung Injury , 2022, The Journal of Immunology.

[12]  M. Nishibori,et al.  Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies , 2022, Nature communications.

[13]  Maxim N. Artyomov,et al.  Immune ageing at single-cell resolution , 2021, Nature Reviews Immunology.

[14]  Ximing Xu,et al.  HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway , 2021, Frontiers in Oncology.

[15]  Yang-shuai Su,et al.  A neuroanatomical basis for electroacupuncture to drive the vagal–adrenal axis , 2021, Nature.

[16]  Leo Y. C. Yan,et al.  Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma , 2021, Angiogenesis.

[17]  Jingjing Cai,et al.  Correlation of blood high mobility group box-1 protein with mortality of patients with sepsis: A meta-analysis. , 2021, Heart & lung : the journal of critical care.

[18]  V. Pavlov,et al.  HMGB1 released from nociceptors mediates inflammation , 2021, Proceedings of the National Academy of Sciences.

[19]  Kaiyue Liu,et al.  HMGB1 could restrict 1,3-β-glucan induced mice lung inflammation by affecting Beclin1 and Bcl2 interaction and promoting the autophagy of epithelial cells. , 2021, Ecotoxicology and environmental safety.

[20]  Y. Levy,et al.  Dynamic autoinhibition of the HMGB1 protein via electrostatic fuzzy interactions between intrinsically disordered regions. , 2021, Journal of molecular biology.

[21]  A. Toutain,et al.  Heterozygous HMGB1 loss‐of‐function variants are associated with developmental delay and microcephaly , 2021, Clinical genetics.

[22]  C. Bruno,et al.  Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy , 2021, Science Translational Medicine.

[23]  Audrey M. Michel,et al.  HMGB1 coordinates SASP‐related chromatin folding and RNA homeostasis on the path to senescence , 2021, Molecular systems biology.

[24]  T. Kaisho,et al.  The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake. , 2021, Immunity.

[25]  Mimi Y. Kim,et al.  Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus , 2021, The Journal of experimental medicine.

[26]  E. Cavalier,et al.  Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression , 2021, Frontiers in Molecular Biosciences.

[27]  P. Delvenne,et al.  Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy , 2021, Journal for ImmunoTherapy of Cancer.

[28]  Je-Jung Lee,et al.  HMGB1 orchestrates STING-mediated senescence via TRIM30α modulation in cancer cells , 2021, Cell Death Discovery.

[29]  Haichao Wang,et al.  Heparin prevents caspase-11-dependent septic lethality independent of anticoagulant properties. , 2021, Immunity.

[30]  M. Bianchi,et al.  HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis , 2021, European journal of immunology.

[31]  U. Sengupta,et al.  Tau Oligomer Induced HMGB1 Release Contributes to Cellular Senescence and Neuropathology Linked to Alzheimer's Disease and Frontotemporal Dementia , 2020, SSRN Electronic Journal.

[32]  Haichao Wang,et al.  HMGB1 as a potential biomarker and therapeutic target for severe COVID-19 , 2020, Heliyon.

[33]  D. Tang,et al.  Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway , 2020, Nature Communications.

[34]  Peter C. DeWeirdt,et al.  Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection , 2020, Cell.

[35]  Haichao Wang,et al.  Extracellular SQSTM1 mediates bacterial septic death in mice through insulin receptor signalling , 2020, Nature Microbiology.

[36]  Min Goo Lee,et al.  Secretory autophagy machinery and vesicular trafficking are involved in HMGB1 secretion , 2020, Autophagy.

[37]  S. Pastorino,et al.  Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy , 2020, Proceedings of the National Academy of Sciences.

[38]  A. Volchuk,et al.  Indirect regulation of HMGB1 release by gasdermin D , 2020, Nature Communications.

[39]  Jian-Min Yuan,et al.  HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions , 2020, Frontiers in Immunology.

[40]  T. Andrews,et al.  NINJ1 mediates plasma membrane rupture during lytic cell death , 2020, Nature.

[41]  P. Tsai,et al.  Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis , 2020, Scientific Reports.

[42]  D. Agrawal,et al.  Vitamin D attenuates HMGB1-mediated neointimal hyperplasia after percutaneous coronary intervention in swine , 2020, Molecular and Cellular Biochemistry.

[43]  W. Wang,et al.  Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients , 2020, Cellular & Molecular Immunology.

[44]  V. Pavlov,et al.  The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation , 2020, Molecular medicine.

[45]  K. Tracey,et al.  Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis , 2020, Science Translational Medicine.

[46]  Peiwei Huangyang,et al.  FBP1 loss disrupts liver metabolism and promotes tumourigenesis through a hepatic stellate cell senescence secretome , 2020, Nature Cell Biology.

[47]  X. Tao,et al.  RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis , 2020, Cell Death & Differentiation.

[48]  Haichao Wang,et al.  TMEM173 Drives Lethal Coagulation in Sepsis. , 2020, Cell host & microbe.

[49]  Yuquan Wei,et al.  Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation , 2020, Autophagy.

[50]  K. Palmblad,et al.  Early stage blockade of the alarmin HMGB1 reduces cartilage destruction in experimental OA. , 2020, Osteoarthritis and cartilage.

[51]  C. Bachert,et al.  Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine , 2019, Journal of Immunotherapy for Cancer.

[52]  M. Lotze,et al.  A peaceful death orchestrates immune balance in a chaotic environment , 2019, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Dey,et al.  Uterine deficiency of high-mobility group box-1 (HMGB1) protein causes implantation defects and adverse pregnancy outcomes , 2019, Cell Death & Differentiation.

[54]  F. Klamt,et al.  Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells , 2019, BMC Cancer.

[55]  M. Nishibori,et al.  Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases. , 2019, Journal of pharmacological sciences.

[56]  Xiaorong Zhu,et al.  Intestinal epithelial HMGB1 inhibits bacterial infection via STAT3 regulation of autophagy , 2019, Autophagy.

[57]  D. Tang,et al.  The release and activity of HMGB1 in ferroptosis. , 2019, Biochemical and biophysical research communications.

[58]  Dragica Gajić,et al.  Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice , 2019, Front. Immunol..

[59]  Guihua Chen,et al.  Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion , 2018, Journal of Immunotherapy for Cancer.

[60]  J. Bertin,et al.  Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death , 2018, Science.

[61]  J. Nichols,et al.  The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase. , 2018, Blood advances.

[62]  Simon C Watkins,et al.  The Endotoxin Delivery Protein HMGB1 Mediates Caspase‐11‐Dependent Lethality in Sepsis , 2018, Immunity.

[63]  D. Klionsky,et al.  PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. , 2018, Developmental cell.

[64]  M. Bianchi,et al.  Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis , 2018, Science Translational Medicine.

[65]  Haichao Wang,et al.  Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis. , 2018, Cell host & microbe.

[66]  K. Tracey,et al.  Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance , 2018, Molecular Medicine.

[67]  Haichao Wang,et al.  High mobility group protein B1 controls liver cancer initiation through yes‐associated protein ‐dependent aerobic glycolysis , 2018, Hepatology.

[68]  T. Billiar,et al.  Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice. , 2018, Blood advances.

[69]  M. Bianchi,et al.  High mobility group box 1 orchestrates tissue regeneration via CXCR4 , 2018, The Journal of experimental medicine.

[70]  H. Leonhardt,et al.  cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein–DNA ladders , 2017, Nature.

[71]  Liangdong Li,et al.  Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis. , 2017, Cancer letters.

[72]  T. Yoshino,et al.  Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice , 2017, Scientific Reports.

[73]  Haichao Wang,et al.  Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer , 2017, Cell Research.

[74]  Yee‐Shin Lin,et al.  Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection , 2017, Scientific Reports.

[75]  E. Alhan,et al.  Ethyl pyruvate treatment ameliorates pancreatic damage: evidence from a rat model of acute necrotizing pancreatitis , 2017, Archives of medical science : AMS.

[76]  E. Alnemri,et al.  Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death , 2017, Nature Communications.

[77]  K. Tracey,et al.  A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis , 2016, Autophagy.

[78]  B. Volpe,et al.  C1q and HMGB1 reciprocally regulate human macrophage polarization. , 2016, Blood.

[79]  Haichao Wang,et al.  PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation , 2016, Nature Communications.

[80]  A. Miyawaki,et al.  HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease , 2016, Scientific Reports.

[81]  M. Weitzman,et al.  A core viral protein binds host nucleosomes to sequester immune danger signals , 2016, Nature.

[82]  K. Tracey,et al.  Edinburgh Research Explorer Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes , 2022 .

[83]  S. Palaniyandi,et al.  Modulation of Macrophage Polarization and HMGB1-TLR2/TLR4 Cascade Plays a Crucial Role for Cardiac Remodeling in Senescence-Accelerated Prone Mice , 2016, PloS one.

[84]  Jonathan C. Fuller,et al.  The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration , 2016, Nature Communications.

[85]  A. Rojas,et al.  HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism , 2016, Tumor Biology.

[86]  P. Limburg,et al.  Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice , 2016, Molecular medicine.

[87]  M. Andrassy,et al.  Critical role of RAGE and HMGB1 in inflammatory heart disease , 2015, Proceedings of the National Academy of Sciences.

[88]  Hao Wu,et al.  Molecular Mechanism of V(D)J Recombination from Synaptic RAG1-RAG2 Complex Structures , 2015, Cell.

[89]  M. Lotze,et al.  DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’ , 2015, Ageing Research Reviews.

[90]  R. Hernández-Pando,et al.  The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis , 2015, PloS one.

[91]  Lei Liu,et al.  Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome , 2015, Cell.

[92]  K. Tracey,et al.  MD-2 is required for disulfide HMGB1–dependent TLR4 signaling , 2015, The Journal of experimental medicine.

[93]  Heshui Wu,et al.  PARP-1 Mediates LPS-Induced HMGB1 Release by Macrophages through Regulation of HMGB1 Acetylation , 2014, The Journal of Immunology.

[94]  Haichao Wang,et al.  HMGB1 in health and disease. , 2014, Molecular aspects of medicine.

[95]  K. Tracey,et al.  Sequestering HMGB1 via DNA-Conjugated Beads Ameliorates Murine Colitis , 2014, PloS one.

[96]  Shulan Zhang,et al.  Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer , 2014, International journal of molecular sciences.

[97]  Xiaorong Zhu,et al.  Hepatocyte‐specific high‐mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: A role for intracellular high‐mobility group box 1 in cellular protection , 2014, Hepatology.

[98]  S. Li,et al.  Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis , 2014, Cell Death and Differentiation.

[99]  K. Tracey,et al.  Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. , 2014, Gastroenterology.

[100]  Taeg S. Kim,et al.  Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism. , 2014, Immunity.

[101]  R. Schwabe,et al.  High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. , 2014, Cell metabolism.

[102]  D. Schadendorf,et al.  Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma , 2014, Nature.

[103]  T. Taniguchi,et al.  Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection , 2013, Proceedings of the National Academy of Sciences.

[104]  Shizuo Akira,et al.  Autophagy in infection, inflammation and immunity , 2013, Nature Reviews Immunology.

[105]  D. Tang,et al.  Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis. , 2013, Biochemical pharmacology.

[106]  K. Tatsch,et al.  Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients , 2013, International journal of cancer.

[107]  S. Akira,et al.  Poly IC triggers a cathepsin D- and IPS-1-dependent pathway to enhance cytokine production and mediate dendritic cell necroptosis. , 2013, Immunity.

[108]  K. Tracey,et al.  HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[109]  K. Tracey,et al.  Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptake. , 2012, Biochemical pharmacology.

[110]  Lin Zhao,et al.  Atorvastatin reduces serum HMGB1 levels in patients with hyperlipidemia , 2012, Experimental and therapeutic medicine.

[111]  K. Tracey,et al.  Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release , 2012, The Journal of experimental medicine.

[112]  H. Yoshiyama,et al.  Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 , 2012, Nature Immunology.

[113]  K. Tracey,et al.  Novel role of PKR in inflammasome activation and HMGB1 release , 2012, Nature.

[114]  Yue Jin,et al.  Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[115]  Wonhwa Lee,et al.  Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[116]  L. Varani,et al.  HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 , 2012, The Journal of experimental medicine.

[117]  K. Tracey,et al.  Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis , 2012, Arthritis Research & Therapy.

[118]  V. Deretic,et al.  Autophagy‐based unconventional secretory pathway for extracellular delivery of IL‐1β , 2011, The EMBO journal.

[119]  Tak W. Mak,et al.  Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit , 2011, Science.

[120]  A. Akaike,et al.  HMGB1 inhibitor glycyrrhizin attenuates intracerebral hemorrhage-induced injury in rats , 2011, Neuropharmacology.

[121]  N. Schaum,et al.  p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes , 2011, The Journal of cell biology.

[122]  Alex M. García,et al.  Diagnostic accuracy of HMGB-1, sTREM-1, and CD64 as markers of sepsis in patients recently admitted to the emergency department. , 2011, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[123]  K. Honda,et al.  Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs) , 2011, Proceedings of the National Academy of Sciences.

[124]  U. Andersson,et al.  Monoclonal Anti-HMGB1 (High Mobility Group Box Chromosomal Protein 1) Antibody Protection in Two Experimental Arthritis Models , 2011, Molecular medicine.

[125]  K. Tracey,et al.  EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. , 2011, Biochemical pharmacology.

[126]  M. Bianchi,et al.  DNA-based strategies for blocking HMGB1 cytokine activity: design, synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes. , 2011, Molecular bioSystems.

[127]  S. Kaveri,et al.  Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock , 2011, Intensive Care Medicine.

[128]  S. Lippard,et al.  Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA. , 2011, Biochemistry.

[129]  Y. Ling,et al.  Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro. , 2011, International immunopharmacology.

[130]  Huan Yang,et al.  Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model. , 2010, Arthritis and rheumatism.

[131]  K. Tracey,et al.  Inflammasome-Dependent Release of the Alarmin HMGB1 in Endotoxemia , 2010, The Journal of Immunology.

[132]  K. Tracey,et al.  Endogenous HMGB1 regulates autophagy , 2010, The Journal of cell biology.

[133]  K. Tracey,et al.  HMGB1 Release and Redox Regulates Autophagy and Apoptosis in Cancer Cells , 2010, Oncogene.

[134]  S. Akira,et al.  A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release , 2010, Proceedings of the National Academy of Sciences.

[135]  S. Akira,et al.  HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses , 2009, Nature.

[136]  Jeon-Soo Shin,et al.  HMGB1 Is Phosphorylated by Classical Protein Kinase C and Is Secreted by a Calcium-Dependent Mechanism1 , 2009, The Journal of Immunology.

[137]  S. Tooze,et al.  Early endosomes and endosomal coatomer are required for autophagy , 2009, The Journal of cell biology.

[138]  Yang Liu,et al.  CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses , 2009, Science.

[139]  M. Bianchi,et al.  Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE , 2008, The Journal of experimental medicine.

[140]  H. Okazawa,et al.  Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain. , 2008, Biochemical and biophysical research communications.

[141]  D. Green,et al.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. , 2008, Immunity.

[142]  U. Andersson,et al.  Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis , 2008, Arthritis research & therapy.

[143]  M. Rosengart,et al.  HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.

[144]  Laurence Zitvogel,et al.  Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.

[145]  H. Møller,et al.  A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study , 2007, Critical care.

[146]  M. Zamai,et al.  Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. , 2007, Chemistry & biology.

[147]  L. Audoly,et al.  Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.

[148]  Haichao Wang,et al.  A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. , 2007, Blood.

[149]  K. Tracey,et al.  A Cardiovascular Drug Rescues Mice from Lethal Sepsis by Selectively Attenuating a Late-Acting Proinflammatory Mediator, High Mobility Group Box 11 , 2007, The Journal of Immunology.

[150]  Haichao Wang,et al.  Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 , 2007, Journal of leukocyte biology.

[151]  H. Rauvala,et al.  Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). , 2007, Journal of leukocyte biology.

[152]  D. Pisetsky,et al.  The extracellular release of HMGB1 during apoptotic cell death. , 2006, American journal of physiology. Cell physiology.

[153]  K. Tracey,et al.  The Aqueous Extract of a Popular Herbal Nutrient Supplement, Angelica sinensis, Protects Mice against Lethal Endotoxemia and Sepsis , 2006, The Journal of Nutrition.

[154]  K. Tracey,et al.  The effects of CpG DNA on HMGB1 release by murine macrophage cell lines , 2005, Journal of leukocyte biology.

[155]  A. Tomkinson,et al.  Reconstitution of 5′-Directed Human Mismatch Repair in a Purified System , 2005, Cell.

[156]  K. Tracey,et al.  The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.

[157]  K. Tracey,et al.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[158]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[159]  M. Yamakuchi,et al.  High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. , 2003, Arthritis and rheumatism.

[160]  K. Tracey,et al.  IFN-γ Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism1 , 2003, The Journal of Immunology.

[161]  Kevin J. Tracey,et al.  Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.

[162]  M. Bianchi,et al.  The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.

[163]  K. Tracey,et al.  Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[164]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[165]  K. Tracey,et al.  High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.

[166]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[167]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[168]  A. Aguzzi,et al.  The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.

[169]  S. Lippard,et al.  Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. , 1992, Science.

[170]  H. Zentgraf,et al.  Nucleosome assembly in vitro: separate histone transfer and synergistic interaction of native histone complexes purified from nuclei of Xenopus laevis oocytes. , 1990, The EMBO journal.

[171]  M. Beltrame,et al.  Specific recognition of cruciform DNA by nuclear protein HMG1. , 1989, Science.

[172]  G. Goodwin,et al.  Isolation and characterisation of two calf-thymus chromatin non-histone proteins with high contents of acidic and basic amino acids. , 1973, European journal of biochemistry.